This topic contains a solution. Click here to go to the answer

Author Question: In a principal-agent problem, if the contract implies that the more risk-averse agent will bear less ... (Read 221 times)

Jipu 123

  • Hero Member
  • *****
  • Posts: 569
In a principal-agent problem, if the contract implies that the more risk-averse agent will bear less risk, we can say that this contract exhibits
 
  A) efficiency in risk-bearing.
  B) risk sharing is not optimal because the less risk-averse (or risk-neutral) agent should bear none of the risk.
  C) risk sharing is not optimal because all risk should be transferred to the most risk-averse agent.
  D) risk sharing is not optimal because risk-neutral agents should face no risk.

Question 2

The situation in which one firm can produce the total output of the market at lower cost than several firms is called a
 
  A) natural monopoly.
  B) pure monopoly.
  C) ruling monopoly.
  D) cost monopoly.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

zoeyesther

  • Sr. Member
  • ****
  • Posts: 315
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 56% of students answer this correctly




Jipu 123

  • Member
  • Posts: 569
Reply 2 on: Jul 1, 2018
Great answer, keep it coming :)


vickybb89

  • Member
  • Posts: 347
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library